Foe S. Tjoeng

1.1k total citations
17 papers, 874 citations indexed

About

Foe S. Tjoeng is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Foe S. Tjoeng has authored 17 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Physiology. Recurrent topics in Foe S. Tjoeng's work include Chemical Synthesis and Analysis (10 papers), Nitric Oxide and Endothelin Effects (4 papers) and Peptidase Inhibition and Analysis (3 papers). Foe S. Tjoeng is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Nitric Oxide and Endothelin Effects (4 papers) and Peptidase Inhibition and Analysis (3 papers). Foe S. Tjoeng collaborates with scholars based in United States and Germany. Foe S. Tjoeng's co-authors include Gina Jerome, William M. Moore, Mark G. Currie, R. Keith Webber, Thomas P. Misko, R. B. Merrifield, George A. Heavner, James P. Tam, Kam F. Fok and Philippe R. Bovy and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Foe S. Tjoeng

17 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Foe S. Tjoeng United States 13 372 335 242 143 100 17 874
James Liebmann United States 11 363 1.0× 302 0.9× 66 0.3× 133 0.9× 69 0.7× 23 1.4k
Godha Rangaraj Canada 22 158 0.4× 861 2.6× 146 0.6× 214 1.5× 46 0.5× 35 1.4k
Takashi Hayama Japan 14 153 0.4× 366 1.1× 335 1.4× 36 0.3× 51 0.5× 42 849
Stephen J. Haleen United States 18 377 1.0× 371 1.1× 121 0.5× 41 0.3× 294 2.9× 31 822
Tsuyoshi Nagase Japan 16 471 1.3× 550 1.6× 347 1.4× 55 0.4× 195 1.9× 30 1.1k
Karl F. Erhard United States 22 115 0.3× 772 2.3× 262 1.1× 34 0.2× 41 0.4× 43 1.4k
Koji Ichimori Japan 10 345 0.9× 237 0.7× 28 0.1× 113 0.8× 105 1.1× 10 798
Katharina Mertsch Germany 16 164 0.4× 245 0.7× 70 0.3× 55 0.4× 27 0.3× 22 760
Birgit Fichtlscherer Germany 8 371 1.0× 286 0.9× 26 0.1× 123 0.9× 159 1.6× 8 742
Sonia Lamontagne Canada 19 302 0.8× 525 1.6× 314 1.3× 145 1.0× 64 0.6× 22 1.3k

Countries citing papers authored by Foe S. Tjoeng

Since Specialization
Citations

This map shows the geographic impact of Foe S. Tjoeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Foe S. Tjoeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Foe S. Tjoeng more than expected).

Fields of papers citing papers by Foe S. Tjoeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Foe S. Tjoeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Foe S. Tjoeng. The network helps show where Foe S. Tjoeng may publish in the future.

Co-authorship network of co-authors of Foe S. Tjoeng

This figure shows the co-authorship network connecting the top 25 collaborators of Foe S. Tjoeng. A scholar is included among the top collaborators of Foe S. Tjoeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Foe S. Tjoeng. Foe S. Tjoeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kramer, Steven W., Foe S. Tjoeng, William M. Moore, et al.. (1998). 2-Iminohomopiperidinium Salts as Selective Inhibitors of Inducible Nitric Oxide Synthase (iNOS). Journal of Medicinal Chemistry. 41(9). 1361–1366. 21 indexed citations
2.
Moore, William M., R. Keith Webber, Kam F. Fok, et al.. (1996). 2-Iminopiperidine and Other 2-Iminoazaheterocycles as Potent Inhibitors of Human Nitric Oxide Synthase Isoforms. Journal of Medicinal Chemistry. 39(3). 669–672. 77 indexed citations
3.
Moore, William M., R. Keith Webber, Kam F. Fok, et al.. (1996). Inhibitors of human nitric oxide synthase isoforms with the carbamidine moiety as a common structural element. Bioorganic & Medicinal Chemistry. 4(9). 1559–1564. 36 indexed citations
4.
Rico, Joseph G., Robert B. Garland, Thomas E. Rogers, et al.. (1995). Potent in Vitro and in Vivo Inhibitors of Platelet Aggregation Based Upon the Arg-Gly-Asp Sequence of Fibrinogen. (Aminobenzamidino)succinyl (ABAS) Series of Orally Active Fibrinogen Receptor Antagonists. Journal of Medicinal Chemistry. 38(13). 2378–2394. 86 indexed citations
5.
Zablocki, Jeffery A., Foe S. Tjoeng, Philippe R. Bovy, et al.. (1995). A novel series of orally active antiplatelet agents. Bioorganic & Medicinal Chemistry. 3(5). 539–551. 30 indexed citations
6.
Moore, William M., R. Keith Webber, Gina Jerome, et al.. (1994). L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase. Journal of Medicinal Chemistry. 37(23). 3886–3888. 394 indexed citations
7.
Panzer‐Knodle, Susan G., et al.. (1991). Aminopeptidase resistant Arg‐Gly‐Asp analogs are stable in plasma and inhibit platelet aggregation. International journal of peptide & protein research. 38(2). 124–130. 12 indexed citations
8.
Tjoeng, Foe S., et al.. (1990). Multiple peptide synthesis using a single support (MPS3). International journal of peptide & protein research. 35(2). 141–146. 31 indexed citations
9.
Olins, Gillian M., Pramod P. Mehta, Delores J. Blehm, et al.. (1987). Phosphorylation of high‐ and low‐molecular‐mass atrial natriuretic peptide analogs by cyclic AMP‐dependent protein kinase. FEBS Letters. 224(2). 325–330. 13 indexed citations
10.
Olins, Gillian M., et al.. (1986). Specific receptors for atriopeptin III in rabbit lung. Biochemical and Biophysical Research Communications. 140(1). 302–307. 28 indexed citations
11.
Tjoeng, Foe S. & George A. Heavner. (1983). Synthesis of a new photolabile support. 4-(2-Chloropropionyl)phenylacetamidomethyl-resin and its application in solid-phase peptide synthesis. The Journal of Organic Chemistry. 48(3). 355–359. 25 indexed citations
12.
DiMarchi, Richard D., et al.. (1983). Synthesis of the protected tridecapeptide (56–68) of the VH domain of mouse myeloma immunoglobulin M603 and its reattachment to resin supports. International journal of peptide & protein research. 22(2). 204–213. 7 indexed citations
13.
Tjoeng, Foe S. & George A. Heavner. (1982). 4-(2-Chloropropionyl)phenylacetoxy-polyethylene glycol: a new photolabile support for liquid phase peptide synthesis. Tetrahedron Letters. 23(43). 4439–4442. 10 indexed citations
15.
Tam, James P., Foe S. Tjoeng, & R. B. Merrifield. (1980). Design and synthesis of multidetachable resin supports for solid-phase peptide synthesis. Journal of the American Chemical Society. 102(19). 6117–6127. 60 indexed citations
16.
Tam, James P., Foe S. Tjoeng, & R. B. Merrifield. (1979). Multi-detachable resin supports for solid phase fragment synthesis. Tetrahedron Letters. 20(51). 4935–4938. 5 indexed citations
17.
Tjoeng, Foe S., James P. Tam, & R. B. Merrifield. (1979). SOLID PHASE SYNTHESIS OF THE PROTECTED 27 – 42 HEXADECAPEPTIDE OF THE HEAVY CHAIN FROM MYELOMA IMMUNOGLOBULIN M603 Elimination of Side Reactions Associated with Glycyl‐2‐oxypropionyl‐resin. International journal of peptide & protein research. 14(3). 262–274. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026